These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30721564)

  • 1. The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation.
    Sartor C; Bachelot L; Godard C; Lager F; Renault G; Gonzalez FJ; Perret C; Gougelet A; Colnot S
    Liver Int; 2019 Apr; 39(4):727-739. PubMed ID: 30721564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.
    Bonzo JA; Ferry CH; Matsubara T; Kim JH; Gonzalez FJ
    J Biol Chem; 2012 Mar; 287(10):7345-56. PubMed ID: 22241473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
    Cozzolino AM; Alonzi T; Santangelo L; Mancone C; Conti B; Steindler C; Musone M; Cicchini C; Tripodi M; Marchetti A
    J Hepatol; 2013 Jan; 58(1):65-72. PubMed ID: 22960426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function.
    Morimoto A; Kannari M; Tsuchida Y; Sasaki S; Saito C; Matsuta T; Maeda T; Akiyama M; Nakamura T; Sakaguchi M; Nameki N; Gonzalez FJ; Inoue Y
    J Biol Chem; 2017 Jun; 292(25):10574-10585. PubMed ID: 28465351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
    J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual β-Catenin and γ-Catenin Loss in Hepatocytes Impacts Their Polarity through Altered Transforming Growth Factor-β and Hepatocyte Nuclear Factor 4α Signaling.
    Pradhan-Sundd T; Liu S; Singh S; Poddar M; Ko S; Bell A; Franks J; Huck I; Stolz D; Apte U; Ranganathan S; Nejak-Bowen K; Monga SP
    Am J Pathol; 2021 May; 191(5):885-901. PubMed ID: 33662348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
    Yao D; Peng S; Dai C
    BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation.
    Utley S; James D; Mavila N; Nguyen MV; Vendryes C; Salisbury SM; Phan J; Wang KS
    J Hepatol; 2014 May; 60(5):1002-9. PubMed ID: 24365171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ.
    Sasaki S; Urabe M; Maeda T; Suzuki J; Irie R; Suzuki M; Tomaru Y; Sakaguchi M; Gonzalez FJ; Inoue Y
    Mol Cell Biol; 2018 Dec; 38(24):. PubMed ID: 30224520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
    Guo S; Lu H
    J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
    Zulehner G; Mikula M; Schneller D; van Zijl F; Huber H; Sieghart W; Grasl-Kraupp B; Waldhör T; Peck-Radosavljevic M; Beug H; Mikulits W
    Am J Pathol; 2010 Jan; 176(1):472-81. PubMed ID: 20008139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
    Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
    Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.
    Liu F; Peng Y; Qian H; Xiao MC; Ding CH; Zhang X; Xie WF
    J Dig Dis; 2024 Apr; 25(4):255-265. PubMed ID: 38837552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
    Yin C; Wang PQ; Xu WP; Yang Y; Zhang Q; Ning BF; Zhang PP; Zhou WP; Xie WF; Chen WS; Zhang X
    Hepatology; 2013 Dec; 58(6):1964-76. PubMed ID: 23775631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
    Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
    J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.